checkAd
    Adaptive Biotechnologies Corporation Aktie
    3,5800
     
    USD
    -1,92 %
    -0,0700 USD
    Letzter Kurs 02:00:00 NMS
    3,5800
     
    USD
    700 STK
    Geldkurs 29.05.24
    3,5900
     
    USD
    4.000 STK
    Briefkurs 29.05.24
    ISIN: US00650F1093 · WKN: A2PLR5 · SYM: ADPT · USA

    Neueste Nachrichten

    Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    29.05.24 · globenewswire · Adaptive Biotechnologies Corporation
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 16.05.2024
    16.05.24 · wO Chartvergleich · ATI
    Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
    07.05.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
    17.04.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
    02.04.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
    27.03.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
    22.02.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
    14.02.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
    29.01.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    27.12.23 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
    09.11.23 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ Assay Across BeiGene’s Lymphoid Malignancy Pipeline
    07.11.23 · globenewswire · Adaptive Biotechnologies Corporation